Skip to main content
logo
Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
28.98
-2.29 (-7.32%)
Oct 1, 2026, 4:00 PM EDT - Market closed

Structure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-214.84-141.2-122.53-89.62-51.32-38.05
Depreciation & Amortization
2.271.6810.320.280.07
Other Amortization
-----0.05
Loss (Gain) From Sale of Assets
-10.25-10.25----
Loss (Gain) From Sale of Investments
-12.69-15.59-18.47-5.98-0.910.03
Stock-Based Compensation
39.8428.9918.798.192.511.49
Other Operating Activities
2.622.211.60.630.350.19
Change in Accounts Receivable
--100----
Change in Accounts Payable
2.144.773.31-0.862.151.9
Change in Other Net Operating Assets
-29.397.19-0.347.830.822.17
Operating Cash Flow
-220.29-222.2-116.64-79.49-46.12-32.16
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.21-3.61-1.29-2.17-0.16-1.21
Sale of Property, Plant & Equipment
10.2510.25----
Investment in Securities
-421.6783.16-357.62-266.18-61.9519.07
Investing Cash Flow
-415.6389.8-358.91-268.34-62.1117.86

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
766.63765.15517.06473.10.030.01
Repurchase of Common Stock
-3.04-0.62---0.01-
Other Financing Activities
-2.06-2.02-1.8-21.57-2.513.24
Financing Cash Flow
761.53762.52515.26451.5329.01103.25

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
125.61630.1139.72103.7-79.2188.95

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-224.5-225.81-117.93-81.66-46.28-33.37
Free Cash Flow Growth
------
Free Cash Flow Per Share
-3.36-3.81-2.24-2.22-14.48-12.30
Levered Free Cash Flow
-119.06-180.03-70.78-51.38-26.08-18.79
Unlevered Free Cash Flow
-119.06-180.03-70.78-51.38-26.08-18.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-27.25-88.042.966.972.974.06
SEC Filings: 10-K · 10-Q